Biennial International LRRK2 Meeting
18-21 June 2024

Aquila Atlantis Hotel, Crete, Greece

Abstract & early booking deadlines: 18 April 2024. 

Register now

Leucine-Rich Repeat Kinase 2 (LRRK2) is the most common genetic cause of Parkinson’s disease (PD). Several penetrant mutations co-segregate with disease within multi-incident families while frequent non-coding variability in the LRRK2 locus is associated with typical late-onset, Lewy body PD. Notably, LRRK2 mutations constitutively increase its kinase activity making it a leading drug target for disease-modification in PD. 

2024 marks the 20th anniversary of the cloning of the LRRK2 gene, and the field is witnessing major advances in our understanding of its function, its role in human disease and therapeutic intervention. We are pleased to welcome you to the next edition of the Biennial International LRRK2 Meeting, to be held in Crete, Greece from 18-21 June 2024, a location with rich history in medical science that is the perfect locale to showcase the very latest in research of this key protein. The conference programme will explore the genetic forms of PD, the LRRK2 gene and the LRRK2 protein as well as basic LRRK2 signaling mechanisms, and physiological and pathological functions of LRRK2. In addition, non-neuronal LRRK2 signaling, particularly with respect to neuroinflammation and the immune system in PD, will be covered as well as the role of LRRK2 in non-PD conditions and current clinical trials.

The diverse and inclusive programme will include opportunities for networking, and an emphasis will be placed on ensuring the event offers early career researchers with the vital opportunities needed to build their wider research networks with leading experts in the field. We are welcoming abstracts for both oral communications and poster presentations, from both industry and academia and across all career stages. The meeting will be of particular interest to those working in biochemistry, neuroscience, biotechnology and pharmaceuticals.

Programme Coordinators

Hardy Rideout, Biomedical Research Foundation of the Academy of Athens

Esther Sammler, University of Dundee

Sabine Hilfiker, New Jersey Medical School 

Adamantios Mamais, University of Florida 

 Register now

Event sponsored by:

Biochemical Journal logo

Denali Therapeutics logo
MedChemExpress logo  MRC PPU Reagents and Services logo

 

Parkinson's Foundation logo


The Michael J Fox Foundation logo 

Yurogen logo

 
   

Meeting endorsed by:

MDS logo  
   


Sponsorship opportunities are available for this meeting. 
For more details and to find out how you can get involved, please contact Hannah Atkins, Sponsorship Manager.

Biochemical Society Bursaries

We offer a wide variety of grants and bursaries to help you attend this event and save money on registration fees! Support is available to cover registration, accessibility, companion costs and more.

Apply for a General Travel Grant or during the registration process for any of the following schemes:

Not a member of the Biochemical Society? Join today and save up to £100 on your registration fee.